Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 11, 2007
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients
Y Daali, S Cherkaoui, F Doffey-Lazeyras, et al.
Fundamental & Clinical Pharmacology
|
November 3, 2010
Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats
M Bancila, J-C Copin, Y Daali, et al.
Molecular Diagnosis & Therapy
|
April 17, 2013
Applications of CYP450 testing in the clinical setting
C F Samer, K Ing Lorenzini, V Rollason, et al.
Current Drug Metabolism
|
October 15, 2010
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability
V Ancrenaz, Y Daali, P Fontana, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 6, 2005
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
F Schenkel, S Rudaz, Y Daali, et al.
British Journal of Pharmacology
|
March 21, 2012
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro
V Ancrenaz, J Desmeules, R James, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 18, 2014
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
N Marsousi, Y Daali, S Rudaz, et al.
Journal of Chromatography. A
|
October 12, 2001
Routine o-glycan characterization in nutritional supplements--a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylation
N T Tran, Y Daali, S Cherkaoui, et al.
European Journal of Clinical Investigation
|
August 17, 2005
Not all statins interfere with clopidogrel during antiplatelet therapy
F Mach, D Senouf, P Fontana, et al.
Clinical Pharmacology and Therapeutics
|
June 7, 2016
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach
N Marsousi, C F Samer, P Fontana, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 11, 2007
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients
Y Daali, S Cherkaoui, F Doffey-Lazeyras, et al.
Fundamental & Clinical Pharmacology
|
November 3, 2010
Two structurally different T-type Ca 2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats
M Bancila, J-C Copin, Y Daali, et al.
Molecular Diagnosis & Therapy
|
April 17, 2013
Applications of CYP450 testing in the clinical setting
C F Samer, K Ing Lorenzini, V Rollason, et al.
Current Drug Metabolism
|
October 15, 2010
Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability
V Ancrenaz, Y Daali, P Fontana, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 6, 2005
Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor
F Schenkel, S Rudaz, Y Daali, et al.
British Journal of Pharmacology
|
March 21, 2012
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro
V Ancrenaz, J Desmeules, R James, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 18, 2014
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model
N Marsousi, Y Daali, S Rudaz, et al.
Journal of Chromatography. A
|
October 12, 2001
Routine o-glycan characterization in nutritional supplements--a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylation
N T Tran, Y Daali, S Cherkaoui, et al.
European Journal of Clinical Investigation
|
August 17, 2005
Not all statins interfere with clopidogrel during antiplatelet therapy
F Mach, D Senouf, P Fontana, et al.
Clinical Pharmacology and Therapeutics
|
June 7, 2016
Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach
N Marsousi, C F Samer, P Fontana, et al.
Page
of 3